| Serial Number | 90056600 |
| Word Mark | COVI-19 IMMUNITY ENHANCER |
| Filing Date | Thursday, July 16, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, April 13, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment of immunological, viral, inflammatory, infectious autoimmune disorders; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations and substances, used internally as liquid medicines syrup, emulsion or suspension or solids as pills or capsules or chewable tablets for the treatment and prevention of viral infections by boosting the immune system to kill viruses, bacteria, coronaviruses including COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the prevention of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations, namely, elixirs for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical products for treating respiratory diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for COVID-19 (SARS-COV-2) and coronavirus; Inhaled pharmaceutical preparations for the treatment of COVID-19 or coronavirus respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations to boost, enhance, induce, or train and educate the immune system for the treatment of COVID-19 disease and immune system related diseases and disorders Dietary and nutritional supplements for therapeutic treatment to boost immune system responses against COVID-19 disease and immune related diseases and disorders; Dietary and nutritional supplements for boosting immune system responses; Pharmaceuticals, namely, immunomodulators, antivirals, antibiotics and anti-inflammatories |
| Goods and Services | Dispensing of pharmaceuticals; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; pharmaceutical advice |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 13, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 13, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | COVImmune Pharma LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lynnwood, WA 98046 |
| Event Date | Event Description |
| Tuesday, April 13, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, April 13, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, September 30, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 30, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 30, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 29, 2020 | ASSIGNED TO EXAMINER |
| Thursday, August 13, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, July 20, 2020 | NEW APPLICATION ENTERED IN TRAM |